Some people are paying more than $10,000 a year for Ozempic and Mounjaro. Source link
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to…
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago.…
Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional…
Ozempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to the popular weight-loss…
Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. Source link
Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose…